Exodus Point Capital Management, LP Point Biopharma Global Inc. Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$6.86 - $10.86 $116,716 - $184,772
17,014 New
17,014 $154,000
Q2 2022

Aug 19, 2022
SELL
$5.6 - $9.5 $1.35 Million - $2.28 Million
-240,515 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$5.46 - $8.13 $466,726 - $694,960
85,481 Added 55.14%
240,515 $1.92 Million
Q4 2021

Feb 11, 2022
BUY
$4.83 - $9.75 $748,814 - $1.51 Million
155,034 New
155,034 $868,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email